F-1/A: Park Ha Biological Technology Co. Ltd. Eyes Nasdaq Listing with 1.2 Million Share IPO

Park Ha Biological Technology Co., Ltd. plans to offer 1,200,000 ordinary shares in an initial public offering, aiming for a Nasdaq listing.

Summary

• Park Ha Biological Technology Co., Ltd., a Cayman Islands-based holding company, is planning an initial public offering of 1,200,000 ordinary shares.
• The company expects the IPO price to be between $5.00 and $7.00 per share.
• The company has applied to list its ordinary shares on the Nasdaq Capital Market under the symbol PHH.
• Park Ha Cayman operates through its subsidiaries in China, specializing in skincare and cosmetic products.
• The company's revenue streams include product sales and franchise fees.
• For the six months ended April 30, 2024, total revenue was $852,928, a decrease from $1,371,587 for the same period in 2023.
• For the year ended October 31, 2023, total revenue was $2,459,102, an increase from $1,919,389 for the year ended October 31, 2022.
• The company's net income decreased to $48,900 for the six months ended April 30, 2024, from $499,796 for the same period in 2023.
• The company's net income increased to $852,042 for the year ended October 31, 2023, from $191,298 for the year ended October 31, 2022.
• The company intends to use the proceeds from the offering for expanding its directly-owned stores, purchasing existing product patents, and acquiring ingredient suppliers.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While there's growth in some areas, there are also significant declines in revenue and net income. The risks associated with operating in China and the competitive industry add to the uncertainty.

Positives

• The company's revenue increased by 28.12% from 2022 to 2023.
• The company's net income increased by 345.40% from 2022 to 2023.
• The company is expanding its reach through a franchise model.
• The company is investing in research and development to create new skincare products.
• The company is enhancing its social media-based sales and marketing capabilities.

Negatives

• The company's revenue decreased by 37.81% for the six months ended April 30, 2024, compared to the same period in 2023.
• The company's net income decreased by 90.22% for the six months ended April 30, 2024, compared to the same period in 2023.
• The company relies on third-party manufacturers for its product formulas.
• The company faces intense competition in the skincare industry.
• The company is subject to legal and operational risks associated with having all business operations in China.

Risks

• The company faces intense competition in the skincare industry.
• The company has limited resources and faces great challenges in building and maintaining a robust supply chain infrastructure.
• The company faces challenges in maintaining product consistency and quality.
• The company is subject to legal and operational risks associated with having all business operations in China.
• The PRC government may intervene or influence the company's operations at any time.
• The company's ordinary shares may be prohibited from trading on a national exchange under the Holding Foreign Companies Accountable Act (the HFCAA) if the Public Company Accounting Oversight Board (the PCAOB) is unable to inspect the company's auditors for two consecutive years.
• The company is required to complete the record filing requirement with the CSRC to list on overseas stock exchanges and may not be able to complete the filing.
• The company is, and will continue to be, a controlled company within the meaning of the Nasdaq Listing Rules.
• The trading price of the Ordinary Shares is likely to be volatile.

Future Outlook

The company expects the number of franchisees to gradually increase, leading to increased franchise fees and market share. The company also expects product sales to increase as it broadens its online sales channels and attracts more customers.

Industry Context

The beauty industry is highly competitive, with intense competition from both domestic and international players. The company must compete with a high volume of new product introductions and a large number of existing products sold by diverse companies across several different distribution channels.

Related Party Transactions

• The Company made advances to Mr. Hengquan Zhang for working capital to be paid on behalf of the Company.
• The Company made advances to Mr. Fujun Yu for working capital to be paid on behalf of the Company.
• The Company received advances from Mr. Fujun Yu as working capital.
• The Company received advances from Ms. Guozhen Liu as working capital.
• The Company received advances from Ms. Xiaoqiu Zhang as working capital.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Shareholders may face difficulties in protecting their interests due to the company being incorporated in the Cayman Islands.
• Shareholders may be subject to risks associated with the company's operations in China.
• Franchisees may benefit from the company's training and support programs.
• Customers may benefit from the company's focus on providing cost-effective solutions to skin problems.

Next Steps

• The company needs to secure final approval for listing on the Nasdaq Capital Market.
• The company needs to complete the filing with the CSRC.
• The company needs to execute its growth strategies, including strengthening product development, improving training practices, enhancing social media marketing, and improving supply chain capacity.

Key Dates

Keywords

IPO, skincare, franchise, cosmetics, Nasdaq, China, Park Ha, offering